Keyphrases
Cannabinoid Receptor 1 (CB1R)
100%
Renal Tubular Epithelial Cells
55%
Obesity
53%
Kidney
47%
Diabetes
42%
Endocannabinoids
32%
Mammalian Target of Rapamycin (mTOR)
31%
Diabetic Nephropathy
27%
Diabetic Kidney Disease
26%
Glucose Transporter 2 (GLUT2)
20%
Kidney Disease
20%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
18%
Chronic Kidney Disease
18%
Diabesity
18%
Insulitis
18%
Immune Cells
18%
Islet
18%
Therapeutic Potential
18%
Kidney Proximal Tubule
16%
CB1 Receptor
15%
Receptor System
13%
Receptor Blockade
13%
Glucose Reabsorption
13%
Endocannabinoid System
13%
Proximal Tubule
12%
Inducible Nitric Oxide Synthase
12%
Kidney Function
12%
Pathophysiology
11%
Metabolic
11%
Metabolic Abnormalities
11%
Medicine and Dentistry
Cannabinoid 1 Receptor
69%
Diabetic Nephropathy
40%
Diabetes
39%
Endocannabinoid
35%
Receptor
23%
Glucose Transporter 2
20%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Chronic Kidney Disease
18%
Nephropathy
16%
Kidney Function
16%
Kidney Proximal Tubule
14%
Diet Induced Obesity
13%
Receptor Blocking
13%
Methionine
13%
Endocannabinoid System
12%
Pathophysiology
11%
Sodium Glucose Cotransporter 2
11%
Bone Remodeling
11%
Cannabinoid
11%
Osteoplasty
11%
Mammalian Target of Rapamycin Complex 1
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 1 Receptor
74%
Endocannabinoid
36%
Diabetic Nephropathy
32%
Receptor
22%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Chronic Kidney Failure
18%
Glucose Transporter 2
15%
Diet Induced Obesity
15%
Cannabinoid 1 Receptor Antagonist
14%
Fatty Liver
14%
Endocannabinoid System
12%
Cytokine
10%